Difference between revisions of "Phosphatase Subfamily PTPRN"
(→Domain Structure) |
|||
| Line 8: | Line 8: | ||
===Domain Structure=== | ===Domain Structure=== | ||
| − | + | PTPRN has a extracellular region, a transmembrane domain and a cytoplasmic region. | |
| − | + | Part of the extracellular region has crystal structure, which has a ferredoxin-like fold <cite>Primo08, Primo11</cite>. Cytoplasmic region has a putative PEST motif, a PDZ domain, a phosphatase domain and another PDZ domain at the C terminus <cite></cite>. | |
| − | + | ||
===Functions=== | ===Functions=== | ||
Revision as of 05:07, 10 March 2015
Phosphatase Classification: Fold CC1: Superfamily CC1: Family PTP: Subfamily PTPRN
Evolution
Domain Structure
PTPRN has a extracellular region, a transmembrane domain and a cytoplasmic region. Part of the extracellular region has crystal structure, which has a ferredoxin-like fold [1, 2]. Cytoplasmic region has a putative PEST motif, a PDZ domain, a phosphatase domain and another PDZ domain at the C terminus [].
Functions
Both human PTPRN and PTPRN2 are abundantly expressed in brain. It is expressed at limited level or even not expressed in other normal tissues [] (see GTEx PTPRN2.
PTPRN (IA-2/ICA512)
PTPRN is an enzymatically inactive due to mutations at catalytic and WPD motifs (???? reference).
PTPRN, aka IA-2 or ICA512 (Islet cell antigen 512), was first isolated from an islet cDNA expression library by screening with human insulin-dependent diabetes mellitus sera [3]. It is an autoantigen of type I diabetes and an intrinsic membrane protein of neurosecretory granules [4, 5]. PTPRN was found in normal human brain, pituitary, pancreas, and brain tumor cell lines, but not in a variety of other normal or tumor tissues [6]. (note: the tissue expression is supported by RNA-seq data from GTEx project).
PTPRN associates with the secretory granules (SGs) of neuroendocrine cells including pancreatic beta-cells. The exocytosis of SGs and insertion of PTPRN in the plasma membrane promotes the calcium-dependent cleavage of PTPRN cytoplasmic domain by mu-calpain, a calcium-dependent, non-lysosomal cysteine proteases (proteolytic enzymes). The cleavage occurs at the plasma membrane and generates an PTPRN cytosolic fragment that is targeted to the nucleus, where it binds the E3-SUMO ligase protein inhibitor of activated signal transducer and activator of transcription-y (PIASy) and up-regulates insulin expression [7].
Meanwhile, PTPRN binds beta2-syntrophin, a modular adapter interacts with proteins in actin cytoskeleton (e.g. utrophin). The association is mediated by PTPRN cytoplasmic region (663-700) and beta2-syntrophin PDZ domain. In vitro mu-calpain cleaves PTPRN at the site within the region mediates PTPRN binding to beta2-syntrophin [8, 9].
Alternative splicing determines differential PTPRN expression in islets compared with thymus and spleen. Islets express full-length mRNA and two alternatively spliced transcripts, whereas thymus and spleen exclusively express an alternatively spliced transcript lacking exon 13. This difference in splicing may play a permissive role in the development of autoimmune responses to PTPRN [10].
References
Error fetching PMID 11289059:
Error fetching PMID 8024693:
Error fetching PMID 11043403:
Error fetching PMID 11483505:
Error fetching PMID 18048354:
Error fetching PMID 21935384:
Error fetching PMID 8144912:
Error fetching PMID 8641276:
Error fetching PMID 15596545:
- Error fetching PMID 18048354:
- Error fetching PMID 21935384:
- Error fetching PMID 8144912:
- Error fetching PMID 8641276:
- Error fetching PMID 8798755:
- Error fetching PMID 8024693:
- Error fetching PMID 15596545:
- Error fetching PMID 11043403:
- Error fetching PMID 11483505:
- Error fetching PMID 11289059:
